文献速递眼底病与葡萄膜炎

超敏微滴数字PCR检测房水MYD88突变辅助诊断玻璃体视网膜淋巴瘤

Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
PubMed 文献 · JAMA Ophthalmol · 2018-01-01

该队列研究纳入63例个体共96份眼液样本,用微滴数字PCR检测MYD88 L265P突变。23例玻璃体视网膜淋巴瘤患者中17例(74%)可检出突变,40例葡萄膜炎患者均未检出。房水与玻璃体液的突变检出高度一致,房水检测敏感性67%、玻璃体75%,两者阳性预测值与特异性均为100%。

要点

  • 房水与玻璃体液中MYD88 L265P突变检出高度一致(配对样本房水检出8/9,89%)。
  • 玻璃体液ddPCR敏感性75%(95%CI 50%-92%),房水敏感性67%(95%CI 42%-92%)。
  • 两种眼液阳性预测值和特异性均为100%,葡萄膜炎患者均未检出突变。

核心结论

  • 房水与玻璃体液样本间MYD88 L265P突变检出高度一致,提示易获取的房水在识别VRL关键体细胞突变方面信息量接近玻璃体液。
  • 该方法可能为VRL的准确诊断、复发检测和治疗监测提供额外的微创工具。

研究设计与样本

  • 队列研究,纳入2005年8月至2017年8月荷兰Utrecht大学医学中心收治患者的房水和玻璃体液样本,检测前对眼液样本随机化并设盲,使用经内部验证的ddPCR平台检测MYD88 L265P。
  • 共纳入63例个体的96份样本,包括23例VRL患者(女10例、男13例,平均[SD]年龄72[7.3]岁)和40例葡萄膜炎患者(女23例、男17例,平均[SD]年龄58[20.9]岁)。

主要发现

  • 23例VRL患者中17例(74%)检出MYD88 L265P,40例葡萄膜炎患者均未检出。
  • 在配对样本中,MYD88 L265P阳性的玻璃体液样本对应的房水样本有8/9(89%)检出突变。
  • 玻璃体液ddPCR敏感性75%(95%CI 50%-92%),房水敏感性67%(95%CI 42%-92%)。
  • 玻璃体液和房水的阳性预测值均为100%,特异性均为100%。
  • 治疗后所有眼液中均不再检出该突变。

关键数值与推荐

  • VRL患者MYD88 L265P检出率74%(17/23)。
  • 玻璃体液ddPCR敏感性75%(95%CI 50%-92%),阳性预测值100%,特异性100%。
  • 房水ddPCR敏感性67%(95%CI 42%-92%),阳性预测值100%,特异性100%。
  • 配对样本中房水对玻璃体液阳性结果的检出率为89%(8/9)。

临床怎么用

  • 房水paracentesis相对玻璃体液取材创伤更小、更安全,房水MYD88突变分析可作为VRL诊断和监测的附加液体活检工具。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The diagnostic workup of patients suspected of having vitreoretinal lymphoma (VRL) is primarily based on vitreous fluid analysis, including the recently emerging myeloid differentiation primary response gene 88 (MYD88) mutation analysis. Aqueous humor paracentesis is a relatively less invasive and safer procedure than taking vitreous fluid specimens, and aqueous humor-based MYD88 mutation analysis would provide an additional liquid biopsy tool to diagnose and monitor patients with VRL. OBJECTIVE: To investigate whether the detection of MYD88 L265P by highly sensitive droplet digital polymerase chain reaction (ddPCR) is feasible in the vitreous fluid and aqueous humor of patients with VRL. DESIGN, SETTING, AND PARTICIPANTS: This cohort study includes aqueous humor and vitreous fluid samples from patients with VRL who were treated at the University Medical Center Utrecht, in Utrecht, the Netherlands, from August 2005 to August 2017. Ocular fluids were randomized and masked before MYD88 L265P analysis, which was performed using an in-house validated ddPCR platform. Patients with uveitis were included as a comparison group. MAIN OUTCOMES AND MEASURES: The presence of MYD88 L265P mutation detected by ddPCR in AH and VF. RESULTS: The study included 96 samples from 63 individuals, including 23 patients with VRL (of whom 10 were female and 13 male, with a mean [SD] age of 72 [7.3] years) and 40 individuals with uveitis (of whom 23 were female and 17 male, with a mean [SD] age of 58 [20.9] years). In 17 of 23 patients with VRL (74%), MYD88 L265P was detected; it was not detected in any of the patients with uveitis. It was detectable in both vitreous fluid and aqueous humor samples. In the paired samples, the mutation was detected in 8 of 9 aqueous humor samples (89%) of the MYD88 L265P-positive vitreous fluid samples. In vitreous fluid, the MYD88 ddPCR test showed a sensitivity of 75% (95% CI, 50%-92%) and a positive predictive value of 100%; in aqueous humor, sensitivity was 67% (95% CI, 42%-92%), and positive predictive value was 100%. Specificity was 100% in both fluids. After treatment, the mutation was no longer detectable in any ocular fluids. CONCLUSIONS AND RELEVANCE: The high concordance between aqueous humor and vitreous fluid samples suggests that use of the easily accessible aqueous humor is nearly as informative as vitreous fluid in the identification of key somatic mutations in patients with VRL. This approach may provide an additional minimally invasive tool for accurate diagnosis, detection of recurrence, and monitoring of treatment.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Hiemcke-Jiwa LS, Ten Dam-van Loon NH, Leguit RJ, et al. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction. JAMA Ophthalmol. 2018. PMID: 30027272. doi:10.1001/jamaophthalmol.2018.2887

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。